GLIDE at the 79th World Health Assembly 2026 in Geneva

The Global Institute for Disease Elimination (GLIDE) is attending the 79th World Health Assembly (WHA79) in Geneva to drive strategic conversations on accelerating the elimination of infectious diseases through global collaboration. By convening policymakers, technical experts, and investors, GLIDE aims to catalyze the high-level partnerships necessary to transition health innovations from small-scale pilots to impactful, global implementations.

Elevating the Global Narrative with Devex

GLIDE is partnering with Devex to lead two high-profile dialogues to tackle key challenges and updates in the global public health realm. The first panel session, titled “Rethinking Elimination: Integration and Innovation for Sustainable Disease Elimination”, explores how disease-specific elimination programs can be integrated into broader primary healthcare systems to ensure long-term sustainability rather than operating in silos.

For more info, please click here

This will be followed by a DevexImpactHouse session, featuring H.E. Dr. Farida Al Hosani, in conversation with Kate Warren, executive vice president & executive editor at Devex, highlighting how AI, advanced data systems, and stronger primary health care can improve targeting, accelerate elimination efforts, and help countries turn global commitments into durable local impact.

For more info, please click here

Advancing the AI Frontier: A Third Consecutive Milestone

Marking the third installment in its flagship series, GLIDE is hosting its “Artificial Intelligence for Health and Disease Elimination: Cross-Sector Action for Impact” roundtable. The session is strategically designed to advance cross-sector collaboration by showcasing applied AI solutions that integrate health, environmental, and epidemiological data systems to support long-term sustainability and disease elimination. By bringing together policymakers, technologists, and investors, the session aims to catalyze the partnerships and pathways necessary to move AI innovation beyond small-scale pilots and toward impactful, scalable implementation across global health systems.

For more info, please click here

Economic Resilience: A Third Convening of Global Experts

Focusing on the critical intersection of finance and health, GLIDE is hosting the third session of its International Working Group on the Economics of Disease Elimination and Integration, serving as a platform for health economists to translate complex analysis into actionable insights for policy and financing decisions. The session aims to drive fruitful dialogue, to ensure economic impact and investment cases remain comparable across different diseases and delivery platforms to protect global health gains during periods of economic instability.

For more info, please click here